NEW APPROACHES IN THE TREATMENT OF METABOLIC  DISORDERS IN LIVER FAILURE

dc.date.accessioned	2025-03-06T03:43:07Z
dc.date.available	2025-03-06T03:43:07Z
dc.date.issued	2024-03-16
dc.identifier.issn	2749-3644
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/1015
dc.description.abstract	Hepatotoxicity is damage caused by exposure to a drug or non- pharmacological agents. Risk factors include: individual intolerance, age, gender, alcohol consumption, smoking, concomitant use of other drugs, liver disease, genetic and environmental factors. [1–3] Although most lipophilic drugs can cause hepatotoxicity , [4] antibiotics, nonsteroidal anti-inflammatory drugs (NSAIDs), and anticonvulsants are the pharmacological groups that are the most common causes. [1, 5-9]. Among the drugs administered intravenously, antibiotics and neoplasia drugs are mostly associated with liver toxicity	en_US
dc.language.iso	en	en_US
dc.publisher	World Bulletin of Public Health (WBPH)	en_US
dc.relation.ispartofseries	volume-32;
dc.subject	Hepatotoxicity, intolerance, age, gender, alcohol consumption, smoking, concomitant use of other drugs, liver disease, genetic and environmental factors.	en_US
dc.title	NEW APPROACHES IN THE TREATMENT OF METABOLIC DISORDERS IN LIVER FAILURE	en_US
dc.type	Article	en_US